Cecilia Jones, Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 3,141 shares at $34.71 ($109K) on 2026-04-02, disclosed to the SEC on 2026-04-06.
Scheduled sale ($109k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AGIO | SELL | 2025-09-30 | $268K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $119K | — | Filing → |
| AGIO | SELL | 2025-03-04 | $141K | — | Filing → |